| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.84B | 39.14B | 39.10B | 38.98B | 36.78B | 36.50B |
| Gross Profit | 12.22B | 12.62B | 12.49B | 15.74B | 15.42B | 15.33B |
| EBITDA | 7.83B | 8.75B | 10.71B | 9.84B | 10.25B | 10.18B |
| Net Income | 222.00M | 1.52B | 2.80B | 4.32B | 4.37B | 4.96B |
Balance Sheet | ||||||
| Total Assets | 94.48B | 97.89B | 100.04B | 102.18B | 98.97B | 105.64B |
| Cash, Cash Equivalents and Short-Term Investments | 18.28B | 22.00B | 19.42B | 18.86B | 14.36B | 20.55B |
| Total Debt | 12.17B | 13.67B | 5.82B | 8.89B | 10.00B | 330.00M |
| Total Liabilities | 20.00B | 23.56B | 13.92B | 18.50B | 18.97B | 9.69B |
| Stockholders Equity | 74.47B | 74.32B | 86.11B | 83.61B | 79.96B | 95.88B |
Cash Flow | ||||||
| Free Cash Flow | 398.00M | 6.53B | 4.49B | 7.95B | 5.46B | -458.00M |
| Operating Cash Flow | 5.86B | 11.76B | 7.18B | 9.27B | 8.51B | 6.89B |
| Investing Cash Flow | -4.84B | -4.12B | -3.33B | -2.04B | -3.82B | -6.99B |
| Financing Cash Flow | -3.88B | -5.46B | -3.89B | -3.14B | -11.05B | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥9.79T | 21.89 | 25.14% | 1.01% | 8.83% | 8.63% | |
73 Outperform | ¥3.21T | 25.64 | 8.98% | 1.22% | 7.68% | 10.08% | |
68 Neutral | ¥954.90B | 24.33 | 11.64% | 0.82% | 13.53% | -7.39% | |
62 Neutral | ¥266.50B | 5.59 | 4.38% | 2.03% | 6.04% | 733.13% | |
59 Neutral | ¥1.75T | 38.56 | 11.34% | 1.01% | 0.42% | 34.76% | |
55 Neutral | ¥143.37B | 67.81 | 0.30% | 1.31% | -2.06% | -79.17% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |